xmlns:atom="http://www.w3.org/2005/Atom"

Regulation 6

SCHEDULE 4Amendments to the list of novel foods in the Annex to Commission Implementing Regulation (EU) 2017/2470 for the authorisation of UV-treated baker’s yeast (Saccharomyces cerevisiae) as a novel food

1.  In Commission Implementing Regulation (EU) 2017/2470, the Annex (list of novel foods) is amended as follows.

2.  In Table 1 (authorised novel foods), for the entry for “UV-treated baker’s yeast (Saccharomyces cerevisiae)” substitute—

UV-treated baker’s yeast (Saccharomyces cerevisiae)Specified food categoryMaximum levels of vitamin D2The novel food must be inactivated for use in infant formula, follow-on formula, processed cereal-based food and food for special medical purposes.
Yeast-leavened breads and rolls5 µg/100 gThe designation of the novel food on the labelling of food containing it is “vitamin D yeast” or “vitamin D2 yeast”.
Yeast-leavened fine bakery wares5 µg/100 g
Food supplements as defined in the Food Supplements (Wales) Regulations 2003(1)In accordance with any relevant requirements contained in regulations applying in relation to Wales and made under regulation 4 of the Nutrition (Amendment etc.) (EU Exit) Regulations 2019(2)
Pre-packed fresh or dry yeast for home baking

45 µg/100 g for fresh yeast

200 µg/100 g for dry yeast

The designation of the novel food on the labelling of food containing it is “vitamin D yeast” or “vitamin D2 yeast”.

The labelling of the novel food must bear a statement that the food is only intended for baking and should not be eaten raw.

The labelling of the novel food must bear instructions for use for the final consumer to ensure a maximum concentration of 5µg/100g of vitamin D2 in the final home-baked product is not exceeded.

Dishes, including ready-to-eat meals (excluding soups and salads)3 µg/100 gThe designation of the novel food on the labelling of food containing it is “vitamin D yeast” or “vitamin D2 yeast”.
Soups and salads5 µg/100 g
Fried or extruded cereal, seed or root-based products5 µg/100 g
Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013(3)In accordance with Regulation (EU) No 609/2013
Processed cereal-based food as defined in Regulation (EU) No 609/2013In accordance with Regulation (EU) No 609/2013
Processed fruit products1.5 µg/100 g
Processed vegetables2 µg/100 g
Bread and similar products5 µg/100 g
Breakfast cereals4 µg/100 g
Pasta, doughs and similar products5 µg/100 g
Other cereal-based products3 µg/100 g
Spices, seasonings, condiments, sauce ingredients, dessert sauces/ toppings10 µg/100 g
Protein products10 µg/100 g
Cheese2 µg/100 g
Dairy desserts and similar products2 µg/100 g
Fermented milk or fermented cream1.5 µg/100 g
Dairy powders and concentrates25 µg/100 g
Milk-based products, whey and cream0.5 µg/100 g
Meat and dairy analogues2.5 µg/100 g
Total diet replacement for weight control as defined in Regulation (EU) No 609/20135 µg/100 g
Meal replacement for weight control5 µg/100 g
Food for special medical purposes as defined in Regulation (EU) No 609/2013In accordance with the particular nutritional requirements of the persons for whom the products are intended

3.  In Table 2 (specifications) for the entry for “UV-treated baker’s yeast (Saccharomyces cerevisiae)” substitute—

UV-treated baker’s yeast (Saccharomyces cerevisiae)

Description/Definition

Baker’s yeast (Saccharomyces cerevisiae) is treated with ultraviolet light to induce the conversion of ergosterol to vitamin D2 (ergocalciferol). Vitamin D2 content in the yeast concentrate varies between 800,000 - 3,500,000 IU vitamin D/100 g (200-875 μg/g).

The yeast is inactivated for use in infant formula, follow-on formula, processed cereal-based food, and food for special medical purposes as defined in Regulation (EU) No 609/2013. The yeast can be active or inactive for use in other foods.

The yeast concentrate is blended with regular baker’s yeast in order not to exceed the maximum level in the pre-packed fresh or dry yeast for home baking.

Tan-coloured, free-flowing granules.

Vitamin D2

Chemical name: (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

Synonym: Ergocalciferol

CAS No.: 50-14-6

Molecular weight: 396.65 g/mol

Microbiological criteria for the yeast concentrate

Coliforms: ≤ 103 CFU/g

Escherichia coli: ≤ 10 CFU/g

Salmonella spp.: Absence in 25 g

CFU: Colony Forming Units.

(1)

S.I. 2003/1719 (W. 186), to which there are amendments not relevant to these Regulations.

(2)

S.I. 2019/651, amended by S.I. 2020/1476 and 2023/28.

(3)

EUR 2013/609, amended by S.I. 2019/651 and 2023/28. S.I. 2019/651 was amended by S.I. 2020/1476 and 2023/28.